References
- KamathSLipGYFibrinogen: biochemistry, epidemiology and determinantsQJM2003961071172914500858
- LominadzeDDeanWLTyagiSCRobertsAMMechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular diseaseActa Physiol (Oxf)20101981113
- SokolovaIAMuravyovAVKhokhlovaMDAn effect of glycoprotein IIb/IIIa inhibitors on the kinetics of red blood cells aggregationClin Hemorheol Microcirc201457329130224081313
- FarrellDHThiagarajanPBinding of recombinant fibrinogen mutants to plateletsJ Biol Chem199426912262318276798
- HolmbackKDantonMJSuhTTDaughertyCCDegenJLImpaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3EMBO J19961521576057718918453
- SalsmannASchaffner-ReckingerEKiefferNRGD, the Rho’d to cell spreadingEur J Cell Biol2006853–424925416546569
- MaedaNSeikeMKumeSTakakuTShigaTFibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen moleculeBiochim Biophys Acta1987904181912959322
- CarvalhoFAConnellSMiltenberger-MiltenyiGAtomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytesACS Nano2010484609462020731444
- CarvalhoFAMartinsICSantosNCAtomic force microscopy and force spectroscopy on the assessment of protein folding and functionalityArch Biochem Biophys20135311–211612723228596
- GuedesAFCarvalhoFAMalhoILousadaSargentoLSantosNCAtomic force microscopy as a tool to evaluate the risk of cardiovascular diseases in patientsNat Nanotechnol201611868769227183056
- CarvalhoFAde OliveiraSFreitasTGonçalvesSSantosNCVariations on fibrinogen-erythrocyte interactions during cell agingPLoS One201163e1816721464904
- GuedesAFCarvalhoFAMoreiraCNogueiraJBSantosNCEssential arterial hypertension patients present higher cell adhesion forces, contributing to fibrinogen-dependent cardiovascular riskNanoscale2017939148971490628949356
- GuedesAFCarvalhoFADominguesMMMacraeFLMcPhersonHRSantosNCAriёnsRASSensing adhesion forces between erythrocytes and γ’ fibrinogen, modulating fibrin clot architecture and functionNanomedicine201814390991829410160
- CarvalhoFASantosNCAtomic force microscopy-based force spectroscopy – biological and biomedical applicationsIUBMB Life201264646547222550017
- StandevenKFCarterAMGrantPJFunctional analysis of fibrin gamma-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffnessBlood2007110390290717435113
- RattoTVRuddRELangryKCBalhornRLMcElfreshMWNonlin-early additive forces in multivalent ligand binding to a single protein revealed with force spectroscopyLangmuir20062241749175716460101
- ThiagarajanPRipponAJFarrellDHAlternative adhesion sites in human fibrinogen for vascular endothelial cellsBiochemistry19963513416941758672453
- BlombackBHesselBHoggDTherkildsenLA two-step fibrinogen – fibrin transition in blood coagulationNature19782755680501505692730
- Hurlet-JensenACumminsHZNosselHLLiuCYFibrin polymerization and release of fibrinopeptide B by thrombinThromb Res19822744194277147212
- MeadeTWNorthWRChakrabartiRHaemostatic function and cardiovascular death: early results of a prospective studyLancet198018177105010546103391
- UndasAAriensRAFibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseasesArterioscler Thromb Vasc Biol20113112e88e9921836064
- WeiselJWStructure of fibrin: impact on clot stabilityJ Thromb Haemost20075Suppl 111612417635717
- WeiselJWThe mechanical properties of fibrin for basic scientists and cliniciansBiophys Chem20041122–326727615572258
- BridgeKIPhilippouHAriensRClot properties and cardiovascular diseaseThromb Haemost2014112590190824899357
- ColletJPSoriaJMirshahiMDusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structureBlood1993828246224697691261